Loading
A phase 3 trial of Ibandronic acid in Metastatic cancer and Prostate cancer, run by Cancer Research UK, completed.
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain is a phase 3 interventional study registered as NCT00082927 by Cancer Research UK, with 580 participants recorded, started 2003-04. Interventions recorded: ibandronate sodium. Conditions recorded: Metastatic Cancer, Pain, Prostate Cancer.
Linked to the drug Ibandronic acid because the registry names it among its interventions and Metastatic cancer and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Shares Ibandronic acid, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Ibandronic acid and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.